TB Research

No Amikacin, No Problem: a Successful Treatment Approach for Pediatric Otomastoiditis Due to Amikacin-Resistant Mycobacterium abscessus

W. Richter, Keira A. Cohen

Antimicrobial Agents and Chemotherapy · 2019-11

Abstract

Pediatric otomastoiditis due to Mycobacterium abscessus can be a devastating infection that presents multiple treatment challenges. Van Wijk et al. report the use of a structured approach with a standardized regimen of intravenous (i.v.), topical, and oral antibiotics and surgical intervention for four pediatric patients with multidrug-resistant Mycobacterium abscessus otomastoiditis. Despite treatment-related adverse events, all four patients achieved sustained cure with this approach.

MeSH terms

  • Amikacin
  • Mycobacterium abscessus
  • Medicine
  • Regimen
  • Antibiotics
  • Adverse effect
  • Aminoglycoside
  • Intensive care medicine
  • Surgery
  • Internal medicine